A Phase I/II Trial of EMD 121974 for Treatment of Patients With Recurrent Anaplastic Gliomas.
Phase of Trial: Phase I/II
Latest Information Update: 21 Jun 2013
At a glance
- Drugs Cilengitide (Primary)
- Indications Glioma
- Focus Adverse reactions; Therapeutic Use
- 21 Jun 2013 Additional lead trial centre added as reported by ClinicalTrials.gov.
- 31 Oct 2006 Status change
- 02 Oct 2005 New trial record.